pharmaphorum

MARCH 7, 2022

The World Health Organization (WHO) announced the opening of a global biomanufacturing hub located in South Korea to provide training to low- and middle-income countries seeking to produce vaccines and other biologics, such as insulin and monoclonal antibodies. . of individuals in low-income countries have received their first dose.

Vaccination 97

Vaccination Vaccine Manufacturing Production 97

Fierce Pharma

JULY 13, 2023

This week on "The Top Line," we discuss the state of digital phenotyping, plus the vaccine patent lawsuits, the smallest insulin pump, and the rest of the week's headlines.

Insulin 74

Insulin Vaccination Vaccine 74

BioPharma Reporter

FEBRUARY 25, 2022

A global biomanufacturing training hub will be established in Korea to serve low- and middle-income countries wishing to produce biologicals such as vaccines, insulin, monoclonal antibodies and cancer treatments.

Insulin 52

Insulin Antibody Vaccination Vaccine 52

Pharmaceutical Technology

MARCH 1, 2023

More than a century after an individual with type 1 diabetes was treated with insulin for the first time, the FDA approved Tzield, the first and only treatment to delay the onset of type 1 diabetes. Also in this month’s issue, we take a look at the innovative type 1 diabetes therapy by Provention Bio called Tzield.

Production 130

Production Insulin FDA Approval Pharma Production 130

The Pharma Data

MAY 4, 2021

The New Zealand Medicines and Medical Devices Safety Authority (Medsafe) has banned the trade in unapproved COVID-19 vaccines for a year to prevent the use of vaccines that may not be safe or effective. . The public could also import personal supplies of vaccines. Medsafe framed the action in the context of public safety. . “In

Vaccination 52

Vaccination Vaccine Manufacturing Medicine 52

The Pharma Data

APRIL 1, 2021

Sanofi to build new facility in Canada to increase global availability of high-dose influenza vaccine. Sanofi announces investment of more than €600 million to build a new vaccine facility in Toronto to increase supply of its differentiated influenza vaccines in Canada, the United States and Europe.

Vaccination 52

Vaccination Vaccine Manufacturing Insulin 52

STAT News

NOVEMBER 11, 2022

And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans.

Insulin 98

Insulin Vaccination Vaccine 98

XTalks

NOVEMBER 23, 2022

Ayesha also talked about the latest positive Phase III trial data that Pfizer recently shared for its maternal RSV vaccine candidate. Hear more about the vaccine trial data, based on which an independent data monitoring committee has recommended that Pfizer file with the FDA for approval.

Life Science 52

Life Science FDA Approval Vaccination Vaccine 52

The Pharma Data

FEBRUARY 18, 2022

Egypt, Kenya, Nigeria, Senegal, South Africa and Tunisia to establish mRNA vaccine production. At the European Union – African Union summit in Brussels today WHO Director-General, Dr Tedros Adhanom Ghebreyesus, announced the first six countries that will receive the technology needed to produce mRNA vaccines on the African continent.

Vaccination 52

Vaccination Vaccine Manufacturing Production 52

The Pharma Data

AUGUST 27, 2020

Obesity can increase the risk of death from coronavirus by nearly 50% and could make a vaccine less effective, according to a new study. . A coronavirus vaccine may also not work as well in obese recipients. The research was conducted by the University of North Carolina (UNC), the Saudi Health Council and the World Bank.

Vaccination 52

Vaccination Vaccine Insulin Research 52

XTalks

DECEMBER 15, 2022

The primary endpoints of DIAGNODE-3 are: preservation of endogenous insulin producing capacity measured as stimulated C-peptide; and. All participants will receive vitamin D for one month, then participants will be randomized 2:1 to receive three intralymphatic injections of Diamyd or matching placebo given one month apart.

Clinical Trials 97

Clinical Trials Clinical Trials Vaccination Vaccine 97

World of DTC Marketing

DECEMBER 3, 2021

” According to data from the People’s Vaccine Alliance, Pfizer, BioNTech, and Moderna make $65k a minute in combined profits from their vaccines, based on profits reported in the three companies’ latest reports. Today pharma is about “business.”

Insulin 259

Insulin Vaccination Vaccine Marketing 259

Pharmaceutical Technology

DECEMBER 27, 2022

Reynald Castaneda wrote about the affected clinical trial ecosystems in both countries , while Fiona Barry and Manasi analysed the impact of the war on the supply of the Russian Covid-19 vaccine Sputnik V to the rest of the world.

Clinical Trials 306

Clinical Trials Clinical Trials Trials Vaccination 306

The Pharma Data

MAY 6, 2021

. US backs giving poorer countries access to COVID-19 vaccine patents, reversing stance ( Reuters ) ( STAT ) ( NYTimes ) ( Endpoints ) ( Harvard Bill of Health ) ( KEI ) ( Patent Docs ). Drugmakers say Biden misguided over vaccine patent waiver ( Reuters ) ( FT ). billion ( Reuters ) ( WSJ ).

Sales 52

Sales Vaccination Vaccine Gene Therapy 52

World of DTC Marketing

JANUARY 27, 2022

Novo Nordisk, for example, raised the price of its widely used Novolog insulin 353 percent from its introduction in 2001 to 2016. Some other insulin makers raised prices even higher. An early hint of Trump’s last-minute action could be found in his administration’s contracts with drug companies in 2020 to develop Covid-19 vaccines.

Drugs 228

Drugs Insulin Vaccination Vaccine 228

XTalks

FEBRUARY 9, 2021

Related: Moderna’s COVID-19 Vaccine Effective Against New Variants. While type 2 diabetes is associated with inflammation, which could potentially explain the link between a COVID-19 infection and ensuing inflammatory response, the reasons for the onset of insulin-dependent type I diabetes is a bit less clear.

Insulin 105

Insulin Immune Response Hormones Research 105

pharmaphorum

JULY 5, 2022

The medicines – which include insulin, oral diabetes agent glibenclamide and cancer chemotherapy oxaliplatin – will be sold under a new Impact brand and are all classed as essential medicines by the World Health Organisation (WHO). ” The post Sanofi makes low-cost medicines pledge for low-income countries appeared first on.

Medicine 110

Medicine Insulin Branding Vaccination 110

World of DTC Marketing

DECEMBER 16, 2021

Pharma CEOs also continue to take in tens of millions of dollars in compensation while people often pay close to $1000 for insulin. How immoral is the profiteering?

Insulin 205

Insulin Pharma Companies Drugs Branding 205

Pharma Packaging Solutions

JUNE 30, 2023

Hormones (such as insulin, glucagon, and growth hormone, to name a few) are produced by recombinant DNA, as are blood factors, thrombolytic agents, interferons, monoclonal antibodies, therapeutic enzymes, and more.

Recombinant DNA Technology 52

Recombinant DNA Technology Packaging Packaging Gene Therapy 52

XTalks

MARCH 8, 2021

Related: Type 1 Diabetes Vaccine: Does Diamyd Have a Winning Formula? GLP-1 receptor agonists lower blood glucose levels by increasing the production of insulin. GLP-1 receptor agonists mimic the action of GLP-1, an intestinal hormone that stimulates the secretion of insulin when blood glucose levels rise. cells in the pancreas.

Insulin 98

Insulin Hormones Clinical Trials Clinical Trials 98

STAT News

NOVEMBER 18, 2022

The document says that public funding for the development of vaccines and treatments should be more transparent, and include provisions to ensure that any resulting products are distributed evenly around the world. The first therapy that delays the onset of type 1 diabetes received approval from the U.S. As of 2019, about 1.9

Insulin 98

Insulin FDA Approval Production Pharmacy 98

FDA Law Blog

AUGUST 14, 2022

Insulin: Any insulin approved under an NDA or BLA and covered under Medicare Part D or a Medicare Advantage plan will have no deductibles starting in 2023 and will have a monthly limit of $35 on copayments. The same will be required under state Medicaid and CHIP programs by October 1, 2023.

Drugs 98

Drugs Manufacturing Insulin Pharmacy 98

XTalks

OCTOBER 26, 2020

Related: Type 1 Diabetes Vaccine: Does Diamyd Have a Winning Formula? Autoantibody screening involves measuring levels of islet autoantibodies (iAb) that recognize antigens found in insulin-producing pancreatic beta cells. The presence of one or more iAbs indicates pancreatic autoimmunity and is consistent with a T1D diagnosis.

Insulin 98

Insulin Packaging Packaging Doctors 98

Pharma Packaging Solutions

NOVEMBER 8, 2023

Pre-filled Syringe Packaging A lot of biopharmaceutical products—such as insulin, vaccines, and many hormone therapies—are parenterally administered. We offer a variety of solutions designed to meet your biologics packaging requirements, no matter how complex.

Packaging 52

Packaging Packaging Pharma Packaging Insulin 52

Pharmaceutical Technology

DECEMBER 22, 2022

New vaccines and therapies for the prevention and treatment of malaria, tuberculosis, human immunodeficiency virus (HIV), neglected tropical diseases (NTDs) and anti-microbial resistance (AMR) will be the focus of the research and investment. The company has founded a non-commercial Global Health Unit to meet these goals. Civica JAAQ Sanofi.

Insulin 130

Insulin Production Development Genetics 130

The Pharma Data

JULY 15, 2021

Protomer has used this approach toward advancing a portfolio of therapeutic candidates, including glucose-responsive insulins that can sense sugar levels in the blood and automatically activate as needed throughout the day.

Insulin 52

Insulin Protein Engineer Development 52

The Pharma Data

DECEMBER 15, 2020

The Phase III trial evaluated the use of the diabetes vaccine Diamyd ® , an antigen-specific immunotherapy based on the auto-antigen GAD (glutamic acid decarboxylase), to induce immunological tolerance and stop the autoimmune destruction of insulin producing cells. People with type 1 diabetes cannot produce insulin.

Development 40

Development Insulin Drugs Clinical Trials 40

Delveinsight

DECEMBER 10, 2020

AstraZeneca’s COVID-19 vaccine data suggest single-dose efficacy. The full data from late-phase trials of AstraZeneca’s COVID-19 vaccine have pointed to the potential for AZD1222 to work after a single dose and limit asymptomatic cases; however, missed main questions regarding the efficacy of the candidate.

Gene Therapy 52

Gene Therapy Gene Vaccination Vaccine 52

The Pharma Data

MAY 13, 2021

The insulin-like effect of muscle contraction. Exercise and insulin sensitivity: a review. AMPK and Exercise: Glucose Uptake and Insulin Sensitivity. The insulin-like effect of muscle contraction. Exercise and insulin sensitivity: a review. AMPK and Exercise: Glucose Uptake and Insulin Sensitivity.

Insulin 52

Insulin Production Protein Sales 52

XTalks

FEBRUARY 8, 2021

They include proteins, monoclonal antibodies and vaccines that are considered to be “ highly similar ” to biological products that have already been approved by the FDA. Significantly, insulin was deemed to be a biologic as of March 23, 2020, making it a reference product for the development of biosimilar versions.

Production 78

Production Insulin Branding Generic Drugs 78

Camargo

NOVEMBER 29, 2021

Section 351 of the Public Health Service (PHS) Act defines a biological product as a “virus, therapeutic serum, toxin, antitoxin, vaccine, blood, blood component or derivative, allergenic product, or analogous product. Biologics include a wide range of products , including: Vaccines. Definition of Biologic Products. Allergenics.

Development 180

Development Protein Production Hormones 180

The Pharma Data

FEBRUARY 23, 2022

The World Health Organization (WHO), the Republic of Korea and the WHO Academy today announced the establishment of a global biomanufacturing training hub that will serve all low- and middle-income countries wishing to produce biologicals, such as vaccines, insulin, monoclonal antibodies and cancer treatments.

Vaccination 52

Vaccination Vaccine Development Production 52

pharmaphorum

JUNE 10, 2021

The need for firms to make a reasonable profit is paramount in today’s world; healthy pharmaceutical research and manufacturing are the keys to ending disease, curing chronic conditions, and discovering new therapies and vaccines that address the latest medical challenges.

Manufacturing 104

Manufacturing Pharma Companies Drugs Pharmacy 104

XTalks

FEBRUARY 9, 2022

Related: Medtronic Expands Two Insulin Pump Recalls, Including One Over Cybersecurity Concerns. Things, therefore, got worse in 2021, which is concerning as it was during the height of COVID-19 pandemic-fighting efforts, including vaccine distribution.

Pharma Companies 98

Pharma Companies Insulin Packaging Packaging 98

Drug Discovery World

MAY 25, 2023

Research has shown that metabolism + inflammation leads to insulin resistance in type 2 diabetes. However, she has identified FFA4, a G protein-coupled receptor (GCPR) with the therapeutic potential to improve insulin sensitivity in metabolic disorders.

Research 52

Research Drugs In-Vitro Insulin 52

The Pharma Data

MAY 17, 2021

Covid-19 Drugmakers Take On Your Favorite TV Shows to Tackle Vaccine Hesitancy ( WSJ ). Administration lifts mask mandate for vaccinated people on federal property ( The Hill ). China backs developing countries’ call to waive IP rights on COVID-19 vaccines ( Reuters ). In Focus: US.

Trials 52

Trials Vaccination Vaccine Scientist 52

The Pharma Data

DECEMBER 2, 2020

The new plant will as a first priority produce recombinant GAD65, the active pharmaceutical ingredient in the therapeutic diabetes vaccine Diamyd ® currently in late-stage clinical development. The diabetes vaccine Diamyd ® is an antigen-specific immunotherapy for the preservation of endogenous insulin production.

Production 52

Production Insulin Vaccination Vaccine 52